EBS Emergent BioSolutions Inc. Common Stock
EBS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
EBS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
EBS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 1 16,7%
- Compra 4 66,7%
- Mantieni 1 16,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
2 analisti · 2026-08-17Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.60 | $0.11 | 0.49% |
| 31 Marzo 2026 | $0.21 | $-0.25 | 0.46% |
| 31 Dicembre 2025 | $-0.43 | $0.11 | -0.54% |
| 30 Settembre 2025 | $1.06 | $-0.12 | 1.2% |
| 30 Giugno 2025 | $0.16 | $-0.49 | 0.65% |
| 31 Marzo 2025 | $0.71 | $0.44 | 0.27% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Stato Patrimoniale 30
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Flusso di cassa 19
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Tassi di Crescita 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | -108,300,000 | 53,200,000 | 54,200,000 | 54,400,000 | -104,900,000 | 53,100,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | -111,300,000 | 56,500,000 | 54,200,000 | 57,300,000 | -107,400,000 | 55,600,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Stato Patrimoniale 30
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Flusso di cassa 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $762M | $750M | · | $888M | $912M | $1.07B | · | $1.12B | $1.16B | $1.07B | · | $1.10B | $1.07B | $977M | · | $1.52B | |
| Net Income TTM | $-134M | $114M | · | $222M | $-112M | $-91M | · | $-423M | $-799M | $-702M | · | $-778M | $-602M | $-393M | · | $48M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -3.1 | 4.3 | · | 2.2 | -2.7 | -2.5 | · | -1.0 | -0.4 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 30.0 | |
| P/S | 0.6 | 0.6 | · | 0.5 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| P / FCF | · | -11.9 | · | · | · | -17.9 | · | · | · | -1.8 | · | · | · | -2.6 | · | · | |
| EV / EBITDA | -7.0 | 24.8 | · | 11.5 | 464.4 | 10.4 | · | 15.0 | -7.7 | 21.0 | · | -5.6 | -5.6 | -21.5 | · | -44.8 | |
| EV / FCF | · | -23.3 | · | · | · | -52.8 | · | · | · | -19.3 | · | · | · | -12.3 | · | · | |
| EV / Revenue | 1.1 | 1.1 | · | 1.0 | 0.8 | 0.7 | · | 0.9 | 1.3 | 1.3 | · | 1.2 | 1.5 | 2.5 | · | 1.2 | |
| Earnings Yield | -32.6% | 23.5% | · | 44.7% | -36.8% | -40.3% | · | -98.6% | -226.5% | -544.7% | · | -449.7% | -162.7% | -75.9% | · | 3.3% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Ricavi | $743M | $1.04B | $1.05B | $1.12B | — |
| Margine Lordo % | — | — | 30.3% | 34.3% | — |
| Margine Operativo % | 13.5% | -10.4% | -69.2% | -15.2% | — |
| Utile netto | $53M | $-191M | $-760M | $-212M | — |
| EPS Diluito | $0.93 | $-3.60 | $-14.85 | $-4.22 | — |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 1.1 | 1.4 | 2.0 | — | — |
| Rapporto corrente | 5.0 | 3.7 | 1.0 | — | — |
| Quick Ratio | 2.2 | 1.6 | 0.5 | — | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $157M | $36M | $-258M | $-150M | — |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 212 filer · $262.9M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 36 (+2 vs trimestre precedente) | 24 (+2 vs trimestre precedente) | 65 (+2 vs trimestre precedente) | 61 (+6 vs trimestre precedente) | +3.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $24.599.540 | 2.935.506 | 9,36% | Azioni |
| STATE STREET CORP | $24.556.367 | 2.929.238 | 9,34% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $23.216.354 | 2.770.448 | 8,83% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.426.271 | 2.198.839 | 7,01% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.062.629 | 1.200.791 | 3,83% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $9.567.235 | 1.141.339 | 3,64% | Azioni |
| OAK HILL ADVISORS LP | $9.329.772 | 1.113.338 | 3,55% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $8.984.910 | 1.072.185 | 3,42% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.626.129 | 1.029.371 | 3,28% | Azioni |
| Prescott Group Capital Management, L.L.C. | $6.475.821 | 772.771 | 2,46% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $5.725.610 | 683.247 | 2,18% | Azioni |
| PRUDENTIAL FINANCIAL INC | $5.719.308 | 682.495 | 2,18% | Azioni |
| D. E. Shaw & Co., Inc. | $5.572.440 | 664.969 | 2,12% | Azioni |
| GOLDMAN SACHS GROUP INC | $4.591.829 | 547.951 | 1,75% | Azioni |
| Allianz Asset Management GmbH | $4.556.885 | 543.781 | 1,73% | Azioni |
| PALISADE CAPITAL MANAGEMENT, LP | $4.316.191 | 515.059 | 1,64% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.306.516 | 513.904 | 1,64% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $4.091.820 | 488.284 | 1,56% | Azioni |
| VANGUARD GROUP INC | $4.091.457 | 331.024 | 1,56% | Azioni |
| Prosight Management, LP | $3.854.398 | 459.952 | 1,47% | Azioni |
| Trexquant Investment LP | $3.753.050 | 447.858 | 1,43% | Azioni |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3.690.745 | 440.423 | 1,40% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $2.966.378 | 353.983 | 1,13% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.863.614 | 341.720 | 1,09% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $2.757.523 | 329.060 | 1,05% | Azioni |
| Values First Advisors, Inc. | $2.526.468 | 301.488 | 0,96% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.420.144 | 288.800 | 0,92% | Opzione Call |
| GLOBEFLEX CAPITAL L P | $2.022.077 | 241.298 | 0,77% | Azioni |
| FMR LLC | $1.790.865 | 213.707 | 0,68% | Azioni |
| Brandywine Global Investment Management, LLC | $1.610.632 | 130.310 | 0,61% | Azioni |
| DEUTSCHE BANK AG\ | $1.591.513 | 189.918 | 0,61% | Azioni |
| Morse Asset Management, Inc | $1.536.339 | 183.334 | 0,58% | Azioni |
| WOLVERINE ASSET MANAGEMENT LLC | $1.465.939 | 174.933 | 0,56% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $1.390.066 | 165.879 | 0,53% | Azioni |
| ARISTEIA CAPITAL, L.L.C. | $1.355.490 | 161.753 | 0,52% | Azioni |
| Squarepoint Ops LLC | $1.240.374 | 148.016 | 0,47% | Azioni |
| CREDIT AGRICOLE S A | $1.225.994 | 146.300 | 0,47% | Azioni |
| FRANKLIN RESOURCES INC | $1.140.518 | 136.100 | 0,43% | Azioni |
| Bank of New York Mellon Corp | $1.107.082 | 132.110 | 0,42% | Azioni |
| BANK OF AMERICA CORP /DE/ | $1.038.232 | 123.894 | 0,39% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.028.000 | 122.700 | 0,39% | Azioni |
| FULLER & THALER ASSET MANAGEMENT, INC. | $946.647 | 112.965 | 0,36% | Azioni |
| SILVER OAK SECURITIES, INCORPORATED | $929.024 | 110.862 | 0,35% | Azioni |
| CITADEL ADVISORS LLC | $850.570 | 101.500 | 0,32% | Opzione Call |
| Soviero Asset Management, LP | $838.000 | 100.000 | 0,32% | Azioni |
| MACKENZIE FINANCIAL CORP | $817.151 | 97.512 | 0,31% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $810.346 | 96.700 | 0,31% | Azioni |
| Cetera Investment Advisers | $807.002 | 96.301 | 0,31% | Azioni |
| UBS Group AG | $801.765 | 95.676 | 0,31% | Azioni |
| SEGALL BRYANT & HAMILL, LLC | $797.818 | 95.205 | 0,30% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785.206 | 93.700 | 0,30% | Opzione Put |
| Sanctuary Advisors, LLC | $746.800 | 89.117 | 0,28% | Azioni |
| MORGAN STANLEY | $734.281 | 87.623 | 0,28% | Azioni |
| MARTINGALE ASSET MANAGEMENT L P | $656.205 | 78.306 | 0,25% | Azioni |
| EVOLVE PRIVATE WEALTH, LLC | $592.801 | 70.740 | 0,23% | Azioni |
| TWO SIGMA ADVISERS, LP | $561.144 | 45.400 | 0,21% | Azioni |
| RHUMBLINE ADVISERS | $560.997 | 66.946 | 0,21% | Azioni |
| Man Group plc | $557.496 | 66.527 | 0,21% | Azioni |
| JANE STREET GROUP, LLC | $552.242 | 65.900 | 0,21% | Opzione Call |
| LPL Financial LLC | $543.828 | 64.896 | 0,21% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $539.334 | 64.980 | 0,21% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $529.624 | 63.201 | 0,20% | Azioni |
| CITIGROUP INC | $527.219 | 62.914 | 0,20% | Azioni |
| JAMES INVESTMENT RESEARCH, INC. | $519.250 | 61.963 | 0,20% | Azioni |
| CITADEL ADVISORS LLC | $506.990 | 60.500 | 0,19% | Opzione Put |
| Palumbo Wealth Management LLC | $490.557 | 58.539 | 0,19% | Azioni |
| IEQ CAPITAL, LLC | $488.152 | 58.252 | 0,19% | Azioni |
| Assenagon Asset Management S.A. | $473.093 | 56.455 | 0,18% | Azioni |
| Mariner, LLC | $467.769 | 55.817 | 0,18% | Azioni |
| FEDERATED HERMES, INC. | $461.621 | 55.086 | 0,18% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $416.939 | 49.754 | 0,16% | Azioni |
| Vanguard Global Advisers, LLC | $407.888 | 48.674 | 0,16% | Azioni |
| Advantage Alpha Capital Partners LP | $405.156 | 45.936 | 0,15% | Azioni |
| Rafferty Asset Management, LLC | $397.463 | 47.430 | 0,15% | Azioni |
| WINTON GROUP Ltd | $383.335 | 45.744 | 0,15% | Azioni |
| Quantinno Capital Management LP | $375.784 | 44.843 | 0,14% | Azioni |
| ExodusPoint Capital Management, LP | $367.731 | 43.882 | 0,14% | Azioni |
| TRUIST FINANCIAL CORP | $365.966 | 43.671 | 0,14% | Azioni |
| WOLVERINE TRADING, LLC | $353.130 | 39.500 | 0,13% | Opzione Put |
| Brevan Howard Capital Management LP | $326.116 | 38.916 | 0,12% | Azioni |
| Integrated Quantitative Investments LLC | $322.638 | 38.501 | 0,12% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $292.462 | 34.900 | 0,11% | Azioni |
| Cambria Investment Management, L.P. | $285.247 | 34.039 | 0,11% | Azioni |
| CWM, LLC | $280.017 | 33.737 | 0,11% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $278.392 | 33.221 | 0,11% | Azioni |
| WOLVERINE TRADING, LLC | $272.670 | 30.500 | 0,10% | Opzione Call |
| OPPENHEIMER ASSET MANAGEMENT INC. | $265.202 | 31.647 | 0,10% | Azioni |
| MetLife Investment Management, LLC | $250.839 | 29.933 | 0,10% | Azioni |
| Keystone Financial Group | $238.730 | 28.488 | 0,09% | Azioni |
| BANK OF MONTREAL /CAN/ | $229.847 | 27.428 | 0,09% | Azioni |
| BlackRock, Inc. | $225.045 | 26.855 | 0,09% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $221.391 | 26.419 | 0,08% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $216.237 | 25.804 | 0,08% | Azioni |
| WOLVERINE TRADING, LLC | $208.928 | 23.370 | 0,08% | Azioni |
| State of Wyoming | $203.408 | 24.273 | 0,08% | Azioni |
| PROFUND ADVISORS LLC | $202.360 | 24.148 | 0,08% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $198.054 | 24.603 | 0,08% | Azioni |
| Glenmede Investment Management, LP | $183.438 | 20.798 | 0,07% | Azioni |
| Graham Capital Management, L.P. | $180.941 | 21.592 | 0,07% | Azioni |
| DIVERSIFIED TRUST CO | $173.625 | 20.719 | 0,07% | Azioni |
Insider aziendali 47 insider · 10 dirigenti · 5 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | Chief Executive Officer | 05 Giugno 2018 S | 197.343 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 08 Giugno 2026 F | 374.083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13 Marzo 2012 A | 26.614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 01 Luglio 2026 S | 159.098 | 0 | 1 | $-25.200 |
| William Hartzel | SVP, Bioservices | 08 Giugno 2026 F | 185.558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 08 Giugno 2026 F | 202.201 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13 Novembre 2015 S | 25.182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14 Marzo 2013 F | 28.000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15 Marzo 2011 A | 18.759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11 Novembre 2010 M | 6.980 | 0 | 0 | $0 |
| John D Fowler JR | Direttore | 30 Aprile 2026 A | 30.350 | 0 | 0 | $0 |
| Fuad El-Hibri | Direttore | 03 Dicembre 2021 J | 206.434 | 0 | 0 | $0 |
| John Niederhuber | Direttore | 18 Maggio 2016 D | 30.300 | 0 | 0 | $0 |
| Shahzad Malik | Direttore | 14 Giugno 2007 A | — | 0 | 0 | $0 |
| Intervac, L.L.C. | Proprietario del 10% | 18 Settembre 2012 J | 4.344.250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | Proprietario del 10% | 27 Maggio 2010 J | 2.265.043 | 0 | 0 | $0 |
| Microscience Investments LTD | Proprietario del 10% | 08 Marzo 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 30 Aprile 2026 A | 149.076 | 0 | 0 | $0 |
| Ronald Richard | — | 30 Aprile 2026 A | 123.761 | 0 | 2 | $-263.101 |
| Keith Katkin | — | 30 Aprile 2026 A | 96.294 | 0 | 1 | $-128.183 |
| Joseph C Papa | — | 29 Aprile 2026 A | 493.153 | 0 | 0 | $0 |
| Kathryn C Zoon | — | 30 Aprile 2025 A | 78.885 | 0 | 0 | $0 |
| Donald W Degolyer | — | 30 Aprile 2025 A | 145.503 | 0 | 0 | $0 |
| Sujata Tyagi Dayal | — | 30 Aprile 2025 A | 97.532 | 0 | 0 | $0 |
| Neal Franklin Fowler | — | 30 Aprile 2025 A | 135.503 | 0 | 0 | $0 |
| Marvin L White | — | 30 Aprile 2025 A | 88.495 | 0 | 0 | $0 |
| Louis W Sullivan | — | 30 Aprile 2025 A | 139.098 | 0 | 0 | $0 |
| Simon C Lowry | — | 06 Marzo 2025 A | 91.982 | 0 | 0 | $0 |
| Jessica Perl | — | 06 Marzo 2025 A | 68.387 | 0 | 0 | $0 |
| Jennifer Lynne Fox | — | 11 Luglio 2024 A | 186.382 | 0 | 0 | $0 |
| Adam Havey | — | 09 Giugno 2023 A | 174.398 | 0 | 0 | $0 |
| Robert Kramer | — | 09 Giugno 2023 A | 506.059 | 0 | 0 | $0 |
| Jerome M Hauer | — | 25 Maggio 2023 A | 57.508 | 0 | 0 | $0 |
| Katherine Strei | — | 28 Febbraio 2023 F | 62.824 | 0 | 0 | $0 |
| Atul Saran | — | 28 Febbraio 2023 F | 86.645 | 0 | 0 | $0 |
| George A Joulwan | — | 26 Maggio 2022 A | 40.244 | 0 | 0 | $0 |
| Karen L. Smith | — | 07 Maggio 2021 F | 11.888 | 0 | 0 | $0 |
| Sean Kirk | — | 31 Marzo 2021 F | 17.776 | 0 | 0 | $0 |
| Sue Bailey | — | 04 Marzo 2021 S | 24.427 | 0 | 0 | $0 |
| Denise Esposito | — | 10 Marzo 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | — | 04 Giugno 2008 S | 1.399.764 | 0 | 0 | $0 |
| Joe M Allbaugh | — | 21 Maggio 2008 A | — | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | — | 28 Marzo 2008 S | 1.269.390 | 0 | 0 | $0 |
| Mauro Gibellini | — | 04 Giugno 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | — | 17 Maggio 2007 P | 1.000 | 0 | 0 | $0 |
| Edward Arcuri | — | 08 Maggio 2007 M | 76.722 | 0 | 0 | $0 |
| Robert Calvin Myers | — | 20 Novembre 2006 C | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23 Agosto 2010 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 78 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| EWO · iShares, Inc. | 24,34% | 347.883 SH | 08 Agosto 2026 | Giornaliero |
| EUFN · iShares Trust | 1,16% | 352.361 SH | 08 Agosto 2026 | Giornaliero |
| MTRA · Invesco Actively Managed Exchange-T… | 1,12% | 11.534 SH | 08 Agosto 2026 | Giornaliero |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 35.928 SH | 08 Agosto 2026 | Giornaliero |
| IDMO · Invesco Exchange-Traded Fund Trust … | 0,66% | 201.926 SH | 08 Agosto 2026 | Giornaliero |
| EZU · iShares, Inc. | 0,54% | 381.737 SH | 08 Agosto 2026 | Giornaliero |
| DMXF · iShares Trust | 0,39% | 26.552 SH | 08 Agosto 2026 | Giornaliero |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,35% | 2.821.000 | 08 Agosto 2026 | Giornaliero |
| IEV · iShares Trust | 0,31% | 37.421 SH | 08 Agosto 2026 | Giornaliero |
| IVLU · iShares Trust | 0,31% | 99.461 SH | 08 Agosto 2026 | Giornaliero |
| IMTM · iShares Trust | 0,30% | 91.595 SH | 08 Agosto 2026 | Giornaliero |
| IXG · iShares Trust | 0,28% | 13.907 SH | 08 Agosto 2026 | Giornaliero |
| IEUR · iShares Trust | 0,26% | 171.214 SH | 08 Agosto 2026 | Giornaliero |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673.051 SH | 08 Agosto 2026 | Giornaliero |
| PABD · iShares Trust | 0,22% | 5.313 SH | 08 Agosto 2026 | Giornaliero |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312.634 SH | 08 Agosto 2026 | Giornaliero |
| EFG · iShares Trust | 0,20% | 236.854 SH | 08 Agosto 2026 | Giornaliero |
| EFV · iShares Trust | 0,19% | 412.501 SH | 08 Agosto 2026 | Giornaliero |
| EFA · iShares Trust | 0,19% | 1.084.946 SH | 08 Agosto 2026 | Giornaliero |
| FSCC · Federated Hermes ETF Trust | 0,17% | 51.825 NS | 31 Maggio 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,17% | 18.243 NS | 31 Maggio 2026 | N-PORT |
| IEFA · iShares Trust | 0,17% | 2.281.517 SH | 08 Agosto 2026 | Giornaliero |
| ESGD · iShares Trust | 0,16% | 138.616 SH | 08 Agosto 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,15% | 91.705 NS | 30 Aprile 2026 | N-PORT |
| IDEV · iShares Trust | 0,15% | 333.751 SH | 08 Agosto 2026 | Giornaliero |
| ACWX · iShares Trust | 0,12% | 96.686 SH | 08 Agosto 2026 | Giornaliero |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2.737.509 SH | 08 Agosto 2026 | Giornaliero |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56.354 SH | 08 Agosto 2026 | Giornaliero |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 22.740 SH | 08 Agosto 2026 | Giornaliero |
| IXUS · iShares Trust | 0,10% | 423.874 SH | 08 Agosto 2026 | Giornaliero |
| CALF · Pacer Funds Trust | 0,10% | 412.173 NS | 30 Aprile 2026 | N-PORT |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655.464 SH | 08 Agosto 2026 | Giornaliero |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4.120.164 SH | 08 Agosto 2026 | Giornaliero |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 757.640 NS | 31 Maggio 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2.270.234 NS | 31 Maggio 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 177.050 SH | 08 Agosto 2026 | Giornaliero |
| GSSC · Goldman Sachs ETF Trust | 0,06% | 67.946 NS | 31 Maggio 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 895 SH | 08 Agosto 2026 | Giornaliero |
| URTH · iShares, Inc. | 0,05% | 28.246 SH | 08 Agosto 2026 | Giornaliero |
| ACWI · iShares Trust | 0,04% | 100.105 SH | 08 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | 0,03% | 269.476 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 98.804 NS | 31 Maggio 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,03% | 283.798 NS | 30 Aprile 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242.129 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45.382 SH | 08 Agosto 2026 | Giornaliero |
| TMFX · RBB Fund, Inc. | 0,02% | 845 NS | 31 Maggio 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,02% | 372.675 NS | 30 Aprile 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1.830 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 118.597 SH | 08 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,02% | 355.059 SH | 08 Agosto 2026 | Giornaliero |